Henry Schein Strengthens European Presence with Acquisitions in Dental, Medical and Veterinary Markets

* Noviko, the leading distributor of veterinary supplies in Czech Republic

* DNA Anthos Impianti, a leading dental equipment distributor in Italy

* Medka, a leading provider of consumables, equipment and technical services to
physicians in Germany

MELVILLE, N.Y.--(Business Wire)--
Henry Schein, Inc. (NASDAQ: HSIC), the largest provider of healthcare products
and services to office-based practitioners in the combined North American and
European markets,today announced the acquisition of leading companies serving
the veterinary, dental and medical markets in certain European countries.
Together these three companies had 2008 sales of approximately €110 million
($150 million). Terms of the transactions were not disclosed. The transactions
recently closed and are expected to be accretive to Henry Schein`s 2009
financial results.

"The acquisitions of Noviko, DNA Anthos Impianti and Medka further strengthen
our leading presence in Europe and bring Henry Schein new veterinary, dental and
medical customers," said Stanley M. Bergman, Chairman and Chief Executive
Officer of Henry Schein. "We look forward to sharing best practices between
these newly-acquired organizations and our existing operations, and to using our
combined strengths to enhance our Pan-European presence."

About Noviko

Noviko is the leading distributor of veterinary supplies in the Czech Republic,
with 2008 sales of approximately €52 million ($70 million). Founded in 1996,
Noviko is headquartered in Brno. Noviko sells products for both small and large
animals, and veterinary clinics. Dr. Jaromir Koudela will continue to serve as
Managing Director of the business.

"Noviko is a clear market leader with a history of commitment to customer
service, and is an excellent complement to our veterinary businesses in the
United Kingdom, Germany, Switzerland, Spain, Austria, Portugal and France," said
Mr. Bergman. "Noviko expands our animal health presence to the Czech Republic
market and provides a base for expansion into the Eastern European markets. With
this acquisition, we believe Henry Schein now is the largest Pan-European animal
health distributor."

About DNA Anthos Impianti

DNA Anthos Impianti (DNA) is the Italian distribution arm of Cefla Dental, a
leading manufacturer of dental equipment, including brands such as Anthos, Stern
Weber, MyRay, Mocom, Castellini, and Suzhou Victor Dental. DNA is a leading
distributor of the Anthos brand of dental equipment in Italy, which is estimated
to have the nation`s largest installed unit base. DNA also sells dental
consumable merchandise and provides technical services. With 2008 sales of
approximately €32 million ($43 million), DNA is headquartered in Imola, and has
14 branches and seven showrooms across the country, complimenting Henry Schein`s
current network of showrooms. Andrea Gentilini will join Henry Schein`s
management team in Italy as General Manager, Equipment.

"DNA is a long-standing leader in the Italian dental equipment market, and adds
national equipment sales and service capabilities to Henry Schein`s offering in
Italy," commented Mr. Bergman. "As part of this transaction we have entered into
a five-year agreement with Cefla to distribute Anthos products in most regions
of Italy on an exclusive basis."

About Medka

Medka is a full-service provider of medical consumables, equipment and technical
services primarily to physicians. Founded in 1920, Medka is headquartered in
Berlin, and had 2008 sales of approximately €27 million ($36 million).
Gerd-Peter Wunderlich, Managing Director of Medka since 1974, and owner of the
Company for the majority of this time, will be responsible for Henry Schein`s
medical business in Germany.

"For nearly 90 years Medka has been serving the needs of physicians across
Germany," commented Mr. Bergman. "With the addition of Medka, Henry Schein
expands our comprehensive range of products, equipment and value-added services
to physicians in Germany. Medka complements our current German operations by
providing geographic coverage throughout Germany."

About Henry Schein

Henry Schein, a Fortune 500 company and a member of the NASDAQ 100 Index, is
recognized for its excellent customer service and highly competitive prices. The
Company`s four business groups - Dental, Medical, International and Technology -
serve more than 550,000 customers worldwide, including dental practitioners and
laboratories, physician practices and animal health clinics, as well as
government and other institutions.

The Company operates through a centralized and automated distribution network,
which provides customers in more than 200 countries with a comprehensive
selection of more than 90,000 national and Henry Schein private-brand products
in stock, as well as more than 100,000 additional products available as
special-order items.

Henry Schein also offers a wide range of innovative value-added practice
solutions for healthcare professionals, such as ArubA, the Company`s electronic
catalog and ordering system. Its leading practice-management software solutions
have an installed user base of more than 52,000 practices, including DENTRIX,
Easy Dental, Oasis and EXACT for dental practices, MicroMD for physician
practices, and AVImark for animal health clinics.

Headquartered in Melville, N.Y., Henry Schein employs over 12,000 people and has
operations or affiliates in 20 countries. The Company`s net sales reached a
record $5.9 billion in 2007. For more information, visit the Henry Schein Web
site at www.henryschein.com.

In accordance with the "Safe Harbor" provisions of the Private Securities
Litigation Reform Act of 1995, we provide the following cautionary remarks
regarding important factors that, among others, could cause future results to
differ materially from the forward-looking statements, expectations and
assumptions expressed or implied herein. All forward-looking statements made by
us are subject to risks and uncertainties and are not guarantees of future
performance. These forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause our actual results, performance
and achievements or industry results to be materially different from any future
results, performance or achievements expressed or implied by such
forward-looking statements. These statements are identified by the use of such
terms as "may," "could," "expect," "intend," "believe," "plan," "estimate,"
"forecast," "project," "anticipate" or other comparable terms. A full discussion
of our operations and financial condition, including factors that may affect our
business and future prospects, is contained in documents we have filed with the
SEC and will be contained in all subsequent periodic filings we make with the
SEC. These documents identify in detail important risk factors that could cause
our actual performance to differ materially from current expectations.

Henry Schein, Inc.
Steven Paladino, 631-843-5500
Executive Vice President &
Chief Financial Officer
steven.paladino@henryschein.com
or
Susan Vassallo, 631-843-5562
Vice President
Corporate Communications
susan.vassallo@henryschein.com

Copyright Business Wire 2009